Prophylactic vaccine
Showing 1 - 25 of >10,000
NSCLC Stage IV, ALK Fusion Protein Expression Trial (Peptide vaccine)
Not yet recruiting
- NSCLC Stage IV
- ALK Fusion Protein Expression
- Peptide vaccine
- (no location specified)
Jul 21, 2023
Vaccine-Preventable Diseases, Hepatitis B Trial in Seongnam-si (CVI-HBV-002)
Completed
- Vaccine-Preventable Diseases
- Hepatitis B
- CVI-HBV-002
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofCHA University Bundang Medical Center
Nov 19, 2023
COVID-19 Trial in Birmingham, Leicester, Manchester (GRT-R910 10 mcg Dose (after AZ), GRT-R910 30 mcg Dose (after AZ), GRT-R910
Recruiting
- COVID-19
- GRT-R910 10 mcg Dose (after AZ)
- +3 more
-
Birmingham, United Kingdom
- +2 more
Aug 15, 2022
Genital Herpes Simplex Type 2 Trial (BNT163, Placebo)
Not yet recruiting
- Genital Herpes Simplex Type 2
- BNT163
- Placebo
- (no location specified)
Jun 21, 2022
HPV Vaccine on Menstrual Cycle in Women of Reproductive Age
Not yet recruiting
- Menstrual Disorder
- Premature Ovarian Failure
- prophylactic HPV vaccine(bivalent HPV、quadrivalent HPV、9-valent HPV)
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Cente
Apr 20, 2023
Hiv Trial (BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum))
Not yet recruiting
- Hiv
- BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum)
- (no location specified)
May 8, 2023
Coronavirus Infection, SARS-CoV 2 Trial in Seongnam-si, Seoul (biological, device, other)
Completed
- Coronavirus Infection
- SARS-CoV 2
- INO-4800
- +2 more
-
Seongnam-si, Gyeonggi-do, Korea, Republic of
- +1 more
Jul 14, 2022
Safety, Vaccine Reaction, Vaccine Adverse Reaction Trial (S.opt.FL COVID-19 pDNA vaccine)
Not yet recruiting
- Safety
- +3 more
- S.opt.FL COVID-19 pDNA vaccine
- (no location specified)
Dec 22, 2021
Ebola Virus Disease Trial in Boende (Ad26.ZEBOV vaccine)
Completed
- Ebola Virus Disease
- Ad26.ZEBOV vaccine
-
Boende, Province De La Tshuapa, Congo, The Democratic Republic of theHôpital Général de Référence de Boende
Jan 3, 2023
SARS-CoV-2 Trial in Worldwide (Covigenix VAX-001 , Covigenix VAX-001)
Recruiting
- SARS-CoV-2
- Covigenix VAX-001 placebo
- Covigenix VAX-001
-
Ouagadougou, Burkina Faso
- +4 more
Jul 23, 2022
Corona Virus Infection, Vaccine, COVID-19 Trial in Russian Federation (CoviVac vaccine (inactivated whole-virion concentrated
Active, not recruiting
- Corona Virus Infection
- +2 more
- CoviVac vaccine (inactivated whole-virion concentrated purified) manufactured by FSBSI "Chumakov FSC R&D IBP RAS"
-
Elektrostal, Moscow Oblast, Russian Federation
- +6 more
Mar 9, 2023
Coronavirus Infections, Vaccine Trial in Russian Federation (CoviVac vaccine (inactivated whole-virion concentrated purified)
Recruiting
- Coronavirus Infections
- Vaccine
- CoviVac vaccine (inactivated whole-virion concentrated purified) manufactured by FSBSI "Chumakov FSC R&D IBP RAS"
- The data from volunteers from the control group
-
Kirov, Russian Federation
- +9 more
Jul 8, 2022
Covid-19, Protection Against COVID-19 Trial in Berlin, Mannheim (BNT162b3)
Completed
- Covid-19
- Protection Against COVID-19
- BNT162b3
-
Berlin, Germany
- +1 more
Jun 24, 2022
Herpes Zoster Trial in Huaian, Lianyungang, Shanghai (RZV, Placebo)
Active, not recruiting
- Herpes Zoster
- RZV
- Placebo
-
Huaian, Jiangsu, China
- +5 more
Jan 20, 2023
COVID-19, Infection Viral, Infections Trial in Bergen, Oslo (VB10.2129, VB10.2210)
Active, not recruiting
- COVID-19
- +2 more
- VB10.2129
- VB10.2210
-
Bergen, Norway
- +1 more
Jan 6, 2023
Covid19 Trial in Khayelitsha (hAd5-S-Fusion+N-ETSD vaccine)
Recruiting
- Covid19
- hAd5-S-Fusion+N-ETSD vaccine
-
Khayelitsha, South AfricaKhayelitsha Clinical Research Site
Mar 28, 2022
COVID-19 Trial in El Segundo, Newport Beach (hAd5-S-Fusion+N-ETSD vaccine)
Active, not recruiting
- COVID-19
- hAd5-S-Fusion+N-ETSD vaccine
-
El Segundo, California
- +1 more
Mar 28, 2022
Healthy Adults Trial (Drep-HIV-PT1 0.2mg and CN54gp140/MPLA-L, DREP-HIV-PT1 1mg and CN54gp140/MPLA-L (see above), DNA-HIV-PT123
Not yet recruiting
- Healthy Adults
- Drep-HIV-PT1 0.2mg and CN54gp140/MPLA-L
- +2 more
- (no location specified)
Apr 9, 2021
![](/image/sponsor/federal_budgetary_research_institution_state_research_center_of_virology_and_biotechnology_"vector")
COVID-19 Trial in Russian Federation (EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of
Completed
- COVID-19
- EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19)
- Placebo (sodium chloride, a 0.9% solution for the preparation of dosage forms for injections)
-
Krasnogorsk, Moscow Region, Russian Federation
- +7 more
Mar 15, 2022
Tuberculosis Trial in Worldwide (M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine, Placebo)
Not yet recruiting
- Tuberculosis
- M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine
- Placebo
-
Bandung, Indonesia
- +59 more
Sep 25, 2023
Genital Warts Trial in Pretoria, Cape Town (Quadrivalent HPV vaccine, Hepatitis B vaccine)
Recruiting
- Genital Warts
- Quadrivalent HPV vaccine
- Hepatitis B vaccine
-
Pretoria, Gauteng, South Africa
- +1 more
Mar 5, 2021
Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls
Completed
- HPV Vaccine
- +2 more
- Quadrivalent HPV [Type 6, 11, 16 and 18] L1 Virus-Like Particle Vaccine
-
Thika, Kiambu, KenyaPartners in Health Research and Development
Jan 12, 2021
Herpes Zoster Trial in Tartu (HZ/su vaccine)
Recruiting
- Herpes Zoster
- HZ/su vaccine
-
Elkridge, Maryland
- +47 more
Jan 6, 2023
Covid19, SARS-CoV Infection Trial (Gam-COVID-Vac, )
Not yet recruiting
- Covid19
- SARS-CoV Infection
- Gam-COVID-Vac
- placebo
- (no location specified)
Dec 4, 2020